Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study - 20/03/20
, Anas M. Saad a, c, 1, ⁎ , Muneer J. Al-Husseini c, Youssef M. Abdel-Gawad c, Obai M. Alsalhani c, Razan Alhaddad d, Bashar Mohamad d, Mohannad Abou Saleh a, Carlos Roberto Simons-Linares aBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | Pancreatic adenocarcinoma incidence trends have been on the rise in the U.S. general population over the past few decades. |
• | A debate over the specific subpopulation driving the rise exists and the contribution of the young population is controversial. |
• | Our results, largest young population cohort reported to the best of our knowledge, show that incidence trends have been relatively stable in the young population in the U.S. since the year 2000. |
Summary |
Introduction |
Pancreatic Ductal Adenocarcinoma (PDAC) is an uncommon yet fatal malignancy with numerous recent reports detailing a significant increase in the overall incidence lately. However, there is limited literature on recent incidence rates of the disease in young individuals. In this study we evaluate PDAC incidence in the US among young patients.
Methods |
Data from 2000 to 2017 was obtained from the Surveillance Epidemiology and End Results ‘SEER’ database and analyzed using the SEER*stat software. The overall incidence, incidence trends, and survival were calculated.
Results |
We selected 667 PDAC patients who met our inclusion criteria. We found the incidence of PDAC among young individuals to be 1.016 (95% CI, 0.940–1.096) per 1,000,000 person-years. Incidence rates were stable over the study period. Higher incidence was found among males [1.240 (95% CI, 1.122-1.366)] and blacks [1.226 (95% CI, 0.999–1.490)]. The 5-year relative survival of young patients with PDAC was 6.8%.
Conclusions |
Among young adults, pancreatic cancer incidence has been stable over the study duration. However, disparities between subpopulations exist and further studies are warranted to better understand those observed differences.
Le texte complet de cet article est disponible en PDF.Keywords : 56 Pancreatic Ductal Adenocarcinoma, Incidence, SEER
Plan
Vol 44 - N° 2
P. 204-210 - avril 2020 Retour au numéro
Article précédent
- The effect of maternal use of telbivudine on neonatal CD4+CD25+ regulatory T cells for the prevention of mother-to-child transmission of hepatitis B virus
- Xinyuan Liang, Peiyan Liu, Zonglin He, Xin Chen, Xiaomin Xiao
- The safety and efficacy of anti-PD-1/anti-PD-L1 antibody therapy in the treatment of previously treated, advanced gastric or gastro-oesophageal junction cancer: A meta-analysis of prospective clinical trials
- Xiaofei Ni, Yanpeng Xing, Xuan Sun, Jian Suo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?